Vaccine prevention of rotavirus infection: Social significance and effectiveness

Vaccine prevention of rotavirus infection: Social significance and effectiveness

The rotavirus is the leading etiologic factor of intestinal infections. Epidemiological studies confirm the high prevalence of rotavirus gastroenteritis in children up to 5 years. WHO recommends the inclusion of routine vaccination against rotavirus infection in the national immunization programs of...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. G. Yuzhakova, G. P. Martynova
Format:	Article
Language:	Russian
Published:	Journal Infectology 2017-06-01
Series:	Журнал инфектологии
Subjects:	rotavirus infection vaccination pentavalent rotavirus vaccine safety effectiveness
Online Access:	https://journal.niidi.ru/jofin/article/view/602
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

VACCINATION AGAINST ROTAVIRUS INFECTION AS A CONTRIBUTION TO CHILDREN'S HEALTH
by: A. G. Yuzhakova, et al.
Published: (2017-12-01)

Rotavirus Infection in Children is an Unsolved Problem. Review of Guidelines for Vaccinal Prevention
by: Alexandr A. Baranov, et al.
Published: (2017-10-01)

The Results of the Mass Immunization Program against Rotavirus Infection of Children of the First year of Life in a Separate Territory of the Moscow Region
by: L. V. Feklisova, et al.
Published: (2019-09-01)

A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China
by: Shaomin Chen, et al.
Published: (2024-12-01)

Epidemic characteristics and effectiveness of vaccine intervention on rotavirus infection: a real-world observational study in Zhejiang Province, China
by: Ziping Miao, et al.
Published: (2025-05-01)

Evaluation of the Cost-Effectiveness of Vaccination of Children with 5-valent Vaccine against Rotavirus Infection in the Russian Federation
by: Alla V. Rudakova, et al.
Published: (2018-01-01)

Rotavirus Epidemiology and Vaccination Tactics
by: V. P. Bondarev, et al.
Published: (2019-06-01)

Сost-effectiveness of pentavalent rotavirus vaccination in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2023-01-01)

Preclinical and clinical development of preventive rotavirus vaccines: special considerations
by: A. S. Korovkin, et al.
Published: (2024-12-01)

New Possibilities of Preventive Immunization for Rotavirus Infection in Russian Federation. Overview of the Innovative Rotavirus Vaccine Profile
by: Leyla S. Namazova-Baranova, et al.
Published: (2023-01-01)

Analysis of Efficacy of Vaccination of Rotavirus Infection of the Republic of Buryatia
by: D. B Andreeva, et al.
Published: (2025-07-01)

Health impact of rotavirus vaccination in China
by: Sharomi Oluwaseun, et al.
Published: (2024-12-01)

Diverse processes in rotavirus vaccine development
by: Xiaochen Lin, et al.
Published: (2025-12-01)

Experience of Vaccination against Rotavirus Gastroenteritis in the Sverdlovsk Region
by: S. S. Smirnova, et al.
Published: (2018-06-01)

Assessment of the epidemiological effects of using of the pentavalent rotavirus vaccine at a low level of vaccination coverage of the target cohort
by: T. A. Kozhakhmetova, et al.
Published: (2019-10-01)

Vaccine Safety and Efficacy in Preventing Rotavirus Infection
by: V. A. Shevtsov, et al.
Published: (2019-12-01)

NEW PREVENTION OPPORTUNITIES OF INFECTIOUS DISEASES. VACCINATION AGAINST ROTAVIRUS
by: T. A. Grechukha, et al.
Published: (2013-11-01)

Recommendations for Rotavirus Vaccine
by: Ping-Ing Lee, et al.
Published: (2013-12-01)

Immunogenicity analysis of a composition of inactivated human rotavirus A strains in mice following immunisation
by: M. V. Kovrizhko, et al.
Published: (2024-12-01)

Rotavirus Infections: Pathophysiology, Symptoms, and Vaccination
by: Karolina Pawłuszkiewicz, et al.
Published: (2025-05-01)

Assessment of reduction of rotavirus infection burden in case of vaccination with a pentavalent vaccine in Russian Federation
by: A. V. Rudakova, et al.
Published: (2014-09-01)

Evaluation of the Incidence of Rotavirus Infection and the Effectiveness of Vaccination in the Khanty-Mansi Autonomous Ugra District in 2014–2018
by: A. A. Girina, et al.
Published: (2020-05-01)

Phylogenetic characteristics and analysis of the antigenic epitopes of Russian rotaviruses in comparison with vaccine strains
by: T. A. Sashina, et al.
Published: (2025-07-01)

VACCINATION AGAINST ROTAVIRUS INFECTION: 10-YEAR GLOBAL EXPERIENCE OF SUCCESSFUL USE
by: Leyla S. Namazova-Baranova, et al.
Published: (2017-09-01)

Epidemiological and clinical significance of rotavirus infection during the vaccination period
by: E. S. Bukhantsova, et al.
Published: (2024-11-01)

A Long-term Retrospective Epidemiological Analysis of the Incidence of Rotavirus Infection in the Altai Krai for 2001–2023
by: T. V. Safyanova, et al.
Published: (2024-09-01)

Modern Features and Particular Issues of Rotavirus Preventive Vaccination
by: Marina V. Fedoseenko, et al.
Published: (2024-12-01)

Factors associated with antibiotic use in children hospitalized for acute viral gastroenteritis and the relation to rotavirus vaccination
by: Muna Omar, et al.
Published: (2024-12-01)

Health economic evaluation of 2-dose and 3-dose rotavirus vaccines in children below 5 years of age in Morocco
by: Ahmed Mohy, et al.
Published: (2024-12-01)

Cost-effectiveness and benefit-risk of rotavirus vaccination in Afghanistan: a modelling analysis informed by post-licensure surveillance
by: Palwasha Anwari, et al.
Published: (2025-07-01)

Changes in vaccine coverage and incidence of acute gastroenteritis and severe rotavirus gastroenteritis in children <5 years in Shibata City, Niigata Prefecture, Japan
by: Tomohiro Oishi, et al.
Published: (2024-12-01)

Modern aspects of laboratory diagnosis and prevention of rotavirus infection in children
by: N. B. Denisyuk
Published: (2015-04-01)

AN EXPLORATION OF THE FEASIBILITY OF INTRODUCING ROTA VACCINE INTO THE ROUTINE EPI SCHEDULE OF BANGLADESH
by: Sojib Bin Zaman, et al.
Published: (2017-06-01)

Сlinical and epidemiological features of rotavirus infections in infants
by: G. P. Martynova, et al.
Published: (2014-09-01)

Suspected adverse events following immunization associated with seperate/combined administration of 13-valent pneumococcal polysaccharide conjugate vaccine and oral pentavalent human rotavirus live attenuated vaccine in age-eligible children in a district of Shanghai
by: CHEN Jinyan, et al.
Published: (2025-03-01)

Indirect Effects of Universal Infant Rotavirus Vaccination: A Narrative Systematic Review
by: Darren Suryawijaya Ong, et al.
Published: (2025-05-01)

Complications with rotavirus: A single center experiences
by: Bilge Aldemir-Kocabaş, et al.
Published: (2016-12-01)

SPREAD AND PRIMARY MANIFESTATIONS OF ROTAVIRUS INFECTION MORBIDITY IN DIFFERENT PARTS OF THE WORLD
by: V. V. Kudryavtsev, et al.
Published: (2013-07-01)

Commentary: Expression of salivary hepcidin and its inducer, interleukin 6 as well as type I interferons are significantly elevated in infants with poor oral rotavirus vaccine take in South Africa
by: Artur Słomka, et al.
Published: (2025-08-01)

Intussusception associated with rotavirus vaccination in a 2-month-old infant: A case report
by: Shu-Wei Hu, et al.
Published: (2024-01-01)